AssetMark Inc’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$721 Hold
47
﹤0.01% 3218
2026
Q1
$675 Hold
47
﹤0.01% 3120
2025
Q4
$707 Hold
47
﹤0.01% 3027
2025
Q3
$678 Sell
47
-250
-84% -$3.55K ﹤0.01% 2874
2025
Q2
$4.24K Hold
297
﹤0.01% 2181
2025
Q1
$4.42K Hold
297
﹤0.01% 2020
2024
Q4
$4.28K Hold
297
﹤0.01% 1964
2024
Q3
$4.7K Hold
297
﹤0.01% 1740
2024
Q2
$4.56K Buy
297
+104
+54% +$1.58K ﹤0.01% 1617
2024
Q1
$3.16K Buy
+193
New +$3.04K ﹤0.01% 1526

Other funds holding BMEZ

AssetMark Inc's BMEZ Position: Q2 2026 in Review

AssetMark Inc held its BlackRock Health Sciences Trust II (BMEZ) position steady in Q2 2026 at 47 shares worth $721. The position accounts for ﹤0.01% of the portfolio, ranked #3218.

AssetMark Inc first reported a position in BMEZ in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.7K in Q3 2024. 41 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • AssetMark Inc held 47 shares of BlackRock Health Sciences Trust II worth $721 as of Q2 2026.
  • AssetMark Inc left its BlackRock Health Sciences Trust II share count unchanged in Q2 2026.
  • BlackRock Health Sciences Trust II made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #3218 holding.
  • AssetMark Inc first reported a position in BlackRock Health Sciences Trust II in Q1 2024 and has held it in 10 quarters since.
  • AssetMark Inc's BlackRock Health Sciences Trust II position peaked at $4.7K in Q3 2024.
  • 41 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.